RECMGMT-L Archives

Records Management

RECMGMT-L@LISTSERV.IGGURU.US

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Content-Type:
text/plain; charset="utf-8"
Date:
Fri, 2 Dec 2016 15:05:41 +0000
Reply-To:
Records Management Program <[log in to unmask]>
Subject:
From:
Glen Sanderson <[log in to unmask]>
Content-Transfer-Encoding:
8bit
In-Reply-To:
MIME-Version:
1.0
Sender:
Records Management Program <[log in to unmask]>
Parts/Attachments:
text/plain (36 lines)
When we buy gas a portion(tax) goes to the roads/infrastructure. Since electric cars don't use gas they pay no road tax and are not contributing to the upkeep of the infrastructure.  What would be the best way to tax them?  Miles that they go annually?

-----Original Message-----
From: Records Management Program [mailto:[log in to unmask]] On Behalf Of Barbara Wyton
Sent: Friday, December 02, 2016 8:50 AM
To: [log in to unmask]
Subject: Re: Friday Pondering-Technology dilemma

External Sender: Use caution with links/attachments.

If the taxes are used for infrastructure costs (roadway upgrades, resurfacing etc) then yes, they should be taxed.

Barbara Wyton
Records Mgmt Specialist
Canadian Facilities
CBS WREF Services

GSK
7333 Mississauga Road North, Mississauga, Ontario, L5N 6L4, Canada [log in to unmask]
Tel+1 905 819 7050


If you previously subscribed to receive commercial electronic messages from GlaxoSmithKline Inc. and no longer wish to receive them, please click here to unsubscribe: http://casl.contactgsk.ca/ Si vous avez déjà consenti à recevoir les messages électroniques commerciaux de GlaxoSmithKline Inc. et ne souhaitez plus les recevoir, veuillez cliquer ici pour vous désabonner: http://casl.contactgsk.ca/fr/ If you previously subscribed to receive commercial electronic messages from GlaxoSmithKline Inc. and no longer wish to receive them, please click here to unsubscribe: https://casl.contactgsk.ca Si vous avez déjà consenti à recevoir les messages électroniques commerciaux de GlaxoSmithKline Inc. et ne souhaitez plus les recevoir, veuillez cliquer ici pour vous désabonner: https://casl.contactgsk.ca/fr GSK monitors email communications sent to and from GSK in order to protect GSK, our employees, customers, suppliers and business partners, from cyber threats and loss of GSK Information. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws and after appropriate consultation.

List archives at http://lists.ufl.edu/archives/recmgmt-l.html
Contact [log in to unmask] for assistance To unsubscribe from this list, click the below link. If not already present, place UNSUBSCRIBE RECMGMT-L or UNSUB RECMGMT-L in the body of the message.
mailto:[log in to unmask]


CONFIDENTIALITY NOTICE:The information in this e-mail may be confidential and/or privileged and protected by work product immunity or other legal rules. No confidentiality or privilege is waived or lost by mistransmission. If you are not the intended recipient or an authorized representative of the intended recipient, you are hereby notified that any review, dissemination, or copying of this e-mail and its attachments, if any, or the information contained herein is prohibited. If you have received this e-mail in error, please immediately notify the sender by return e-mail and delete this e-mail from your computer system. Thank you.

List archives at http://lists.ufl.edu/archives/recmgmt-l.html
Contact [log in to unmask] for assistance
To unsubscribe from this list, click the below link. If not already present, place UNSUBSCRIBE RECMGMT-L or UNSUB RECMGMT-L in the body of the message.
mailto:[log in to unmask]

ATOM RSS1 RSS2